A WHO-recommended prenatal supplement did not cut small-for-gestational-age births
In a trial of 1,944 pregnant women in rural Sarlahi, a daily fortified energy-protein supplement left the rate of small-for-gestational-age birth essentially unchanged, with only small gains in two secondary measures.
The World Health Organization recommends balanced energy–protein supplementation for pregnant women in undernourished populations as a way to reduce stillbirth and small-for-gestational-age (SGA) birth. A large community trial in southern Nepal has now tested one carefully specified version of that intervention against no supplement, and found it did not reduce the share of babies born small for their gestational age [s1].
What the trial did
The study was the pregnancy arm of MINT, the Maternal Infant Nutrition Trial — a 2 × 2 factorial, household-randomised, unblinded efficacy trial run in Sarlahi, Nepal [s1]. It compared a daily fortified balanced energy–protein supplement given during pregnancy, lactation, or both, against no supplement, and this analysis isolates the effect of the pregnancy supplement on birth outcomes [s1]. The programme is registered as NCT03668977 [s2].
A total of 1,944 pregnant women were enrolled and randomly assigned to receive the daily fortified supplement or not, between November 2021 and August 2023 [s1]. The primary outcome was SGA, defined as a birth weight below the 10th centile, among live-born infants whose weight was measured within 72 hours of delivery [s1]. Of 1,581 live births, 1,209 infants had anthropometry recorded inside that 72-hour window and entered the primary analysis, which used a modified intention-to-treat approach with log-binomial and linear regression models [s1].
What it found
Supplementation did not reduce SGA. The relative risk was 0.99 (95% confidence interval 0.86 to 1.13) — a result sitting almost exactly on no effect, with an interval that rules out any large benefit [s1]. The authors report that maternal short stature, age, adherence and other factors did not significantly change this result [s1]. There was likewise no difference between the groups in low birth weight or in short-for-gestational-age (below the 10th centile for length) [s1].
Two secondary measures did shift, modestly. Mean birth weight was 37.4 grams higher in the supplement group, but the confidence interval crossed zero (95% CI −6.9 to 81.8), so that difference is not statistically reliable [s1]. Mean birth length was 0.20 cm higher, again with an interval spanning no effect (95% CI −0.03 to 0.43) [s1]. Where the signal was clearer was head circumference, higher by 0.23 cm in the supplement group (95% CI 0.09 to 0.38), and weight-for-gestational-age, higher by 2.82 percentage points on the centile scale (95% CI 0.53 to 5.12) and by 0.09 z-scores (95% CI −0.00 to 0.19) [s1]. The authors note these secondary differences were attenuated slightly after adjustment for covariates [s1].
How to read it
A null result on the primary outcome is not the same as a failed study — it is an answer, and in nutrition science a well-run negative trial is unusually valuable. The headline finding is that this particular fortified supplement, delivered daily during pregnancy in a rural, undernourished setting, did not move the rate of SGA birth [s1].
Several features shape how far that answer travels. The trial was unblinded, which is common for a food intervention but means the supplement group knew they were being supplemented [s1]. The effect on growth was concentrated in secondary measures — head circumference and weight-for-gestational-age centile — rather than in the clinical endpoints of SGA or low birth weight, and even the birth-weight and birth-length differences were not statistically significant [s1]. The authors themselves frame the increases as small [s1]. Because the field has struggled to reach consensus precisely because the composition of these supplements varies so widely, a result for one formulation in one population does not settle the question for all of them [s1].
What to watch
The open questions are whether the small gains in head circumference and weight-for-gestational-age translate into anything measurable in infant and child growth — the fuller MINT dataset, which also randomised supplementation during lactation, is designed to probe that — and whether supplements with different energy, protein or micronutrient content perform differently in comparable settings. For now, the honest summary is narrow and useful: in rural Nepal, a daily fortified balanced energy–protein supplement during pregnancy did not reduce small-for-gestational-age births, though it produced small increases in two measures of newborn size [s1].
This article describes trial results and is not medical or nutritional advice. Decisions about supplementation in pregnancy belong with a person's own clinician.
Sources
- Impact of supplementation with fortified balanced energy–protein during pregnancy on birth outcomes: a community-based randomized trial among pregnant females in southern Nepal — The American Journal of Clinical Nutrition , November 1, 2026
- Maternal Infant Nutrition Trial (MINT) (NCT03668977) — ClinicalTrials.gov
Omega-3 capsules moved blood pressure and inflammation markers in a small pilot
In 100 adults already treated for high blood pressure and high cholesterol, 12 weeks of 2 g/day omega-3 was linked to lower daytime and central blood pressure — but the authors call the signals exploratory.
What does ginger actually do? The evidence for nausea and joint pain
Ginger's strongest evidence is unglamorous: it eases nausea in pregnancy and during chemotherapy, and modestly relieves osteoarthritis pain. The trials are small and the quality is moderate at best.
Vitamin E supplements: no heart or cancer benefit, and a harm signal
The large trials built to confirm vitamin E's promise came back null, and a meta-analysis tied 400 IU a day or more to a small rise in all-cause mortality.
Vitamin A: lifesaving where children lack it, useless-to-risky where they don't
In deficient populations, vitamin A supplements cut child deaths by 12% — among the best-evidenced global-health interventions. In the well-nourished, added vitamin A does no good and can do harm.